Found 9 matching trials
Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects PHASE1 The Safety, Tolerability, Pharmacokinetic and Food Effect Study of HEC12250...
Show More Location
Shanghai Xuhui Central Hospital
Learn More & Join Trial
A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients PHASE2 The main goal of this phase llb study is to compare the efficacy and safety...
Show More Location
China-Japan Friendship Hospital
Learn More & Join Trial
The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects PHASE1 The Safety, Tolerability and Pharmacokinetic Study of idiopathic pulmonary ...
Show More Location
Covance Clinical Research Unit, Inc.
Learn More & Join Trial
Study on the Body Mass Balance and Biotransformation of [14C]-HEC585 PHASE1 This is a single-centre, open-label, non-randomised, single-dose study in h...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects PHASE1 The Safety, Tolerability Pharmacokinetic and Food Effect Study of HEC585 in...
Show More Location
Shanghai Xuhui Central Hospital
Learn More & Join Trial
To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers PHASE1 An open label study to evaluate drug-drug interactions between HEC585 and P...
Show More Location
Shanghai Xuhui Central Hospital
Learn More & Join Trial
Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF PHASE3 A multicenter, parallel, randomized, placebo (double-blind) and pirfenidone...
Show More Location
China-Japan Friendship Hospital
Learn More & Join Trial
Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects PHASE1 A single-center, open-label study designed to assess the drug-drug interact...
Show More Location
Shanghai Xuhui Central Hospital
Learn More & Join Trial
Phase ll Study of HEC585 in Patients With IPF PHASE2 A Phase ll Study to evaluate the efficacy and safety of various doses of HE...
Show More Status
Active Not Recruiting
Location
China-Japan Friendship Hospital
Learn More & Join Trial